Business & Finance

MDS reports Q4 2006 consolidated revenue from continuing operations of $291 million

Published in Lab Law Weekly, January 12th, 2007

MDS Inc. (MDS), a provider range of products and services to the life sciences markets, reported fourth quarter 2006 consolidated revenue, adjusted EBITDA and EPS from continuing operations of $291 million, $25 million and 12 cents, respectively. Adjusted EPS, which reflects only continuing businesses, was 3 cents versus 10 cents last year.

Throughout 2006, MDS has been executing on its strategy to transition to a global life sciences company. The company successfully divested a number of nonstrategic businesses, increased productivity and became more effective through significant workforce realignments as well as enhancing the leadership talent across the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry